Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (3434)	11/23/1999 6:14:00 PM
From: NEIL MACK	Read Replies (1) \| Respond to of 4140

Very high after market trade volume has moved the stock price incremently from closing, now clear up to $12.00, as of print at 6:08pm.....indicating a huge gap up, for tomorrow open. Neil

To: BostonView who wrote (3434)	11/23/1999 7:38:00 PM
From: Joe	Read Replies (3) \| Respond to of 4140

BV, the application is still up to +2.5 diopters which is what the initial approval will be limited to. They have an amendment in to collect clinical data up to +5.6 diopters or so. I think they will also be able to collect same day/second eye data for that one. The stock was up to 12 5/8 in aftermarket trading. Some of the shorts following Pluvia and Auric Goldfinger covered a while back but I don't know if A@P folks have covered. If they haven't, there is going to be a huge squeeze giving us longs a nice prize on turkey day. Today was interesting in the options market, but kaboom tomorrow. We will have 10 to 25% of the open interest trading. The specialists are going to eat the shorts alive and spit out the pits on Thanksgiving. Regards, Joe